Skip to main content
Clinical Trials/CTRI/2013/04/003556
CTRI/2013/04/003556
Completed
Phase 3

Add-on use of magnesium sulphate in children with bronchiolitis - ADIVMAG

Deptt of Pediatrics Lady Hardinge Medical College0 sites78 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Bronchiolitis
Sponsor
Deptt of Pediatrics Lady Hardinge Medical College
Enrollment
78
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Deptt of Pediatrics Lady Hardinge Medical College

Eligibility Criteria

Inclusion Criteria

  • First or second episode of bronchiolitis.
  • Moderate to severe disease (composite score 15 or more) after initial therapy with nebulized epinephrine.

Exclusion Criteria

  • 1\.Presence of clinical evidence of Heart Disease
  • 2\.Chronic lung disease
  • 3\.Patients with the requirement of mechanical ventilation initially.
  • 4\. Children with neurological conditions like Cerebral Palsy, Global Developmental Delay, post meningitic or enchephalitic sequale.
  • 5\.Premature birth (defined as birth before 36 weeks of gestation).
  • 6\.Immunosuppression or immunodeficiency or treatment with corticosteroids in the previous 14 days.

Outcomes

Primary Outcomes

Not specified

Similar Trials